Oregon Gov. Kate Brown on Tuesday signed legislation that allows dispensaries to sell marijuana-infused edibles and extracts to people 21 and older. The Oregon Health Authority must first draft rules for the new products before shops can begin selling them.

Gov. Kate Brown on Tuesday signed a bill that allows anyone 21 and older to purchase marijuana extracts and pot-infused edibles from Oregon dispensaries.

The provision is part of Senate Bill 1511, which also allows recreational pot shops to sell tax-free medical marijuana to patients.

“There’s a freight train coming,” Equities CEO Enzo Villani tells BE Senior Personal Finance Editor Stacey Tisdale, in reference to the emerging cannabis industry in the United States.

Like it or not, the legalized marijuana industry is spreading like wildfire in America, as 23 states and the District of Columbia have legalized the plant in some form.

The Oregon Health Authority says the production of cannabis extract is now a class B felony.

An Oregon Health Authority announcement that unlicensed production of marijuana concentrates will be considered a felony has effectively shut down Oregon's extraction industry for more than two weeks.

At a March 15 forum hosted by the Oregon Cannabis Association at Refuge PDX, marijuana business owners were surprised to learn that, under a law that went into effect March 3, unlicensed production of cannabis extracts—potent oils used to make concentrates and edibles— is considered a class B state felony.

To find out where this past weekend’s Marijuana Job Fair was being held, you had to text a guy—because of course you did.

The crowd lined up outside 15 Mercer Street in Toronto’s Entertainment District early Sunday afternoon suggested hundreds had done so in hopes of landing a job in an industry poised for growth, as pot legalization—part of the Liberals’ platform in the last federal election—eventually approaches.

Inside, anyone expecting kiosks and brochures would have been disappointed. Although if the absence of resumes in the hands of attendees and the smell of pot wafting down the street were any indication, it’s doubtful many were upset by the laid-back setup.

The cannabis industry made $5.4 billion in 2015. Legally. That's $5.4 billion worth of businesses growing and cultivating plants, processing and shipping products, and selling marijuana, cannabis oil, and all manner of edibles at dispensaries. That figure is forecast to hit $22.8 billion by 2020 according to the latest State of Legal Marijuana Markets Report from ArcView Market Research and cannabis-focused data analysis firm, New Frontier.

Already a pioneer in high-tech and cutting-edge agriculture, Israel is starting to attract American companies looking to bring medical marijuana know-how to a booming market back home.

Since 2014, U.S. firms have invested about $50 million (34.9 million pounds) in licensing Israeli medical marijuana patents, cannabis agro-tech startups and firms developing delivery devices such as inhalers, said Saul Kaye, CEO of iCAN, a private cannabis research hub.

"I expect it to grow to $100 million in the coming year," Kaye said at iCAN's CannaTech conference in Tel Aviv this month, one of the largest gatherings of medical marijuana experts.

March 31 marks a new day in Detroit for medical marijuana. It's the last day for Medical Marijuana Caregiver Centers to apply for a license to operate in the city.

Before this, provisioning centers multiplied in a gray area of the law where they weren't exactly legal but were tolerated. That's an outgrowth of how Michigan's medical marijuana law played out when the courts ruled patients can have marijuana but didn't allow for venues to sell it. It's right in line with the weird machinations prohibitionists have always gone through to keep people away from the weed.

Legalisation and acceptance of medical cannabis as a cure or therapy for certain clinical ailments is gaining global traction.

As cities across the globe act to industrialise medical cannabis, several companies have begun to position themselves as first movers in product development and distribution.

MMJ Phytotech (ASX:MMJ) is one such company establishing itself in this space.

MMJ is developing quickly and has identified key priorities moving forward, one is to leverage its offshore operations in Australia by importing CBD capsules from Switzerland which are similar to those currently selling in Europe.

Ethan Nadelmann, executive director of the Drug Policy Alliance (DPA) and one of the most recognized speakers in drug-policy circles, doesn’t mince words when he gets up to talk at marijuana industry events. “Frankly,” he often says, “I am not interested in meeting most you.” The only people he wants to talk to, he tells his audiences, are those who are going to make a lot of money in the new marijuana industry in an ethical way and are interested in certain social issues that could make them ideal foot soldiers in the wider struggle against the global war on drugs.

As a veteran in commercial financing for marijuana businesses, I have seen many business owners struggle to obtain funding. There are several common mistakes I’ve seen time and time again. I’ll cover the top six mistakes I often see and what to avoid when seeking funding for your business.